Skip to main content
Top
Published in: Endocrine 1/2017

01-10-2017 | Original Article

Development of metabolic syndrome in high-sucrose diet fed rats is not associated with decrease in adiponectin levels

Authors: M. Aslam, S. V. Madhu

Published in: Endocrine | Issue 1/2017

Login to get access

Abstract

Purpose

Association of circulating adiponectin levels with metabolic syndrome has been controversial, with studies reporting low as well as high circulating adiponectin levels in metabolic syndrome. Present study aims to examine prospectively the course of circulating adiponectin levels during development of metabolic syndrome in a diet-induced rat model of metabolic syndrome.

Methods

In a prospective study, eight-week-old male wistar rats were randomized into two groups (n = 24 each). Group A: standard chow diet and group B: high sucrose diet. Body weight, total and high molecular weight (HMW) adiponectin and insulin levels were measured during the study. Oral fat and glucose tolerance tests were done during the study at various time points from weeks 2 to 26. Visceral fat, subcutaneous fat, and adiponectin levels were also measured at week 48 in some of the rats.

Results

Significantly higher total adiponectin levels were found from week 2 to 26 in group B compared to group A (P = <0.05), whereas HMW adiponectin levels were similar in both the groups. Postprandial triglycerides, obesity, insulin resistance, and glucose intolerance were also found to be significantly higher in group B compared to group A during this period (P = <0.05). Total adiponectin levels of week 26 showed significant positive correlation with preceding postprandial triglyceride burden in group B (r = 0.60, P = 0.002).

Conclusion

In conclusion, the present study finds that development of metabolic syndrome in high-sucrose diet fed rats is not associated with decrease in circulating adiponectin levels.
Literature
1.
go back to reference A.H. Berg, T.P. Combs, P.E. Scherer, ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 13(2), 84–89 (2002)CrossRefPubMed A.H. Berg, T.P. Combs, P.E. Scherer, ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 13(2), 84–89 (2002)CrossRefPubMed
2.
go back to reference A.H. Berg, T.P. Combs, X. Du et al., The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7(8), 947–953 (2001)CrossRefPubMed A.H. Berg, T.P. Combs, X. Du et al., The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7(8), 947–953 (2001)CrossRefPubMed
3.
go back to reference S. Shetty, C.M. Kusminski, P.E. Scherer, Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol. Sci. 30(5), 234–239 (2009)CrossRefPubMed S. Shetty, C.M. Kusminski, P.E. Scherer, Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol. Sci. 30(5), 234–239 (2009)CrossRefPubMed
4.
go back to reference C.E. Juge-Aubry, E. Henrichot, C.A. Meier, Adipose tissue: a regulator of inflammation. Best Pract. Res. Clin. Endocrinol. Metab. 19(4), 547–566 (2005)CrossRefPubMed C.E. Juge-Aubry, E. Henrichot, C.A. Meier, Adipose tissue: a regulator of inflammation. Best Pract. Res. Clin. Endocrinol. Metab. 19(4), 547–566 (2005)CrossRefPubMed
5.
go back to reference P.A. Kern, G.B. Di Gregorio, T. Lu et al., Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance and tumor necrosis factor-alpha expression. Diabetes 52(7), 1779–1785 (2003)CrossRefPubMed P.A. Kern, G.B. Di Gregorio, T. Lu et al., Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance and tumor necrosis factor-alpha expression. Diabetes 52(7), 1779–1785 (2003)CrossRefPubMed
6.
go back to reference V. Mohan, R. Deepa, R. Pradeepa et al., Association of low adiponectin levels with the metabolic syndrome-the Chennai urban rural epidemiology study (CURES-4). Metabolism 54(4), 476–481 (2005)CrossRefPubMed V. Mohan, R. Deepa, R. Pradeepa et al., Association of low adiponectin levels with the metabolic syndrome-the Chennai urban rural epidemiology study (CURES-4). Metabolism 54(4), 476–481 (2005)CrossRefPubMed
8.
go back to reference M. Santaniemi, Y. Antero Kesaniemi, Ukkola Olavi, Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur. J. Endocrinol. 155, 745–750 (2006)CrossRefPubMed M. Santaniemi, Y. Antero Kesaniemi, Ukkola Olavi, Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur. J. Endocrinol. 155, 745–750 (2006)CrossRefPubMed
9.
go back to reference M. Ichimura, S. Kato, K. Tsuneyama et al., Phycocyanin prevents hypertension and low serum adiponectin level in a rat model of metabolic syndrome. Nutr. Res. 33(5), 397–405 (2013)CrossRefPubMed M. Ichimura, S. Kato, K. Tsuneyama et al., Phycocyanin prevents hypertension and low serum adiponectin level in a rat model of metabolic syndrome. Nutr. Res. 33(5), 397–405 (2013)CrossRefPubMed
10.
go back to reference A. Margoni, D.N. Perrea, I. Vlachos et al., Serum leptin, adiponectin and tumor necrosis factor-α in hyperlipidemic rats with/without concomitant diabetes mellitus. Mol. Med. 17(1–2), 36–40 (2011)CrossRefPubMed A. Margoni, D.N. Perrea, I. Vlachos et al., Serum leptin, adiponectin and tumor necrosis factor-α in hyperlipidemic rats with/without concomitant diabetes mellitus. Mol. Med. 17(1–2), 36–40 (2011)CrossRefPubMed
11.
go back to reference M. Sumiyoshi, M. Sakanaka, Y. Kimura, Chronic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice. J. Nutr. 136(3), 582–587 (2006)PubMed M. Sumiyoshi, M. Sakanaka, Y. Kimura, Chronic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice. J. Nutr. 136(3), 582–587 (2006)PubMed
12.
go back to reference C. Bonnard, A. Durand, H. Vidal et al., Changes in adiponectin, its receptors and AMPK activity in tissues of diet induced diabetic mice. Diab. Metab. 34, 52–61 (2008)CrossRef C. Bonnard, A. Durand, H. Vidal et al., Changes in adiponectin, its receptors and AMPK activity in tissues of diet induced diabetic mice. Diab. Metab. 34, 52–61 (2008)CrossRef
13.
go back to reference F. Ziemke, C.S. Mantzoros, Adiponectin in insulin resistance: lessons from translational research. Am. J. Clin. Nutr. 91, 258S–261S (2010)CrossRefPubMed F. Ziemke, C.S. Mantzoros, Adiponectin in insulin resistance: lessons from translational research. Am. J. Clin. Nutr. 91, 258S–261S (2010)CrossRefPubMed
14.
go back to reference Y. Arita, S. Kihara, N. Ouchi et al., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257(1), 79–83 (1999)CrossRefPubMed Y. Arita, S. Kihara, N. Ouchi et al., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257(1), 79–83 (1999)CrossRefPubMed
15.
go back to reference P. Dandona, A. Aljada, A. Chaudhuri et al., Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes and inflammation. Circulation 111(11), 1448–1454 (2005)CrossRefPubMed P. Dandona, A. Aljada, A. Chaudhuri et al., Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes and inflammation. Circulation 111(11), 1448–1454 (2005)CrossRefPubMed
16.
go back to reference O.A. Mojiminiyi, N.A. Abdella, M. Al Arouj et al., Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Int. J. Obes. (Lond) 31(2), 213–220 (2007)CrossRef O.A. Mojiminiyi, N.A. Abdella, M. Al Arouj et al., Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Int. J. Obes. (Lond) 31(2), 213–220 (2007)CrossRef
17.
go back to reference J.M. Shikany, C.E. Lewis, B.I. Freedman et al., Plasma adiponectin concentrations and correlates in African Americans in the Hypertension Genetic Epidemiology Network (HyperGEN) study. Metabolism 56(8), 1011–1016 (2007)CrossRefPubMed J.M. Shikany, C.E. Lewis, B.I. Freedman et al., Plasma adiponectin concentrations and correlates in African Americans in the Hypertension Genetic Epidemiology Network (HyperGEN) study. Metabolism 56(8), 1011–1016 (2007)CrossRefPubMed
18.
go back to reference T. Yamauchi, Y. Nio, T. Maki et al., Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13(3), 332–339 (2007)CrossRefPubMed T. Yamauchi, Y. Nio, T. Maki et al., Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13(3), 332–339 (2007)CrossRefPubMed
19.
go back to reference Y. Liu, M.D. Michael, S. Kash et al., Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. Endocrinology 148(2), 683–692 (2007)CrossRefPubMed Y. Liu, M.D. Michael, S. Kash et al., Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. Endocrinology 148(2), 683–692 (2007)CrossRefPubMed
21.
go back to reference A.P. Doumatey, A.R. Bentley, J. Zhou et al., Paradoxical hyperadiponectinemia is associated with the metabolically healthy obese (MHO) phenotype in african americans. J Endocrinol. Metab. 2(2), 51–65 (2012)PubMedPubMedCentral A.P. Doumatey, A.R. Bentley, J. Zhou et al., Paradoxical hyperadiponectinemia is associated with the metabolically healthy obese (MHO) phenotype in african americans. J Endocrinol. Metab. 2(2), 51–65 (2012)PubMedPubMedCentral
22.
go back to reference C.A. Aguilar-Salinas, E.G. García, L. Robles et al., High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J. Clin. Endocrinol. Metab. 93(10), 4075–4079 (2008)CrossRefPubMed C.A. Aguilar-Salinas, E.G. García, L. Robles et al., High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J. Clin. Endocrinol. Metab. 93(10), 4075–4079 (2008)CrossRefPubMed
23.
go back to reference J.A. Morrison, C.J. Glueck, S. Daniels et al., Paradoxically high adiponectin and the healthy obese phenotype in obese black and white 16-year-old girls. Transl. Res. 156(5), 302–308 (2010)CrossRefPubMedPubMedCentral J.A. Morrison, C.J. Glueck, S. Daniels et al., Paradoxically high adiponectin and the healthy obese phenotype in obese black and white 16-year-old girls. Transl. Res. 156(5), 302–308 (2010)CrossRefPubMedPubMedCentral
24.
go back to reference M. Suzuki, D. Yamamoto, T. Suzuki. et al., Effect of fructose-rich high-fat diet on glucose sensitivity and atherosclerosis in non human primate. Methods Find. Exp. Clin. Pharmacol. 28, 609–617 (2006)CrossRefPubMed M. Suzuki, D. Yamamoto, T. Suzuki. et al., Effect of fructose-rich high-fat diet on glucose sensitivity and atherosclerosis in non human primate. Methods Find. Exp. Clin. Pharmacol. 28, 609–617 (2006)CrossRefPubMed
25.
go back to reference T. Fanatsu, H. Kakuta, T. Takasu et al., Experimental model of postprandial hypertriglyceridemia in sucrose fed rats and the effectiveness of atorvastatin in the model. Metabolism 52(5), 609–615 (2003)CrossRef T. Fanatsu, H. Kakuta, T. Takasu et al., Experimental model of postprandial hypertriglyceridemia in sucrose fed rats and the effectiveness of atorvastatin in the model. Metabolism 52(5), 609–615 (2003)CrossRef
26.
go back to reference Y. Mori, H. Nakagiri, H. Kondo et al., Dietary diacylglycerol reduces postprandial hyperlipidemia and ameliorates glucose intolerance in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Nutrition 21(9), 933–939 (2005)CrossRefPubMed Y. Mori, H. Nakagiri, H. Kondo et al., Dietary diacylglycerol reduces postprandial hyperlipidemia and ameliorates glucose intolerance in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Nutrition 21(9), 933–939 (2005)CrossRefPubMed
27.
go back to reference J. Cacho, J. Sevillano, J. de Castro et al., Validation of simple indexes to assess insulin sensitivity during pregnancy in wistar and sprague-dawley rats. Am. J. Physiol. Endocrinol. Metab. 295(5), E1269–1276 (2008)CrossRefPubMed J. Cacho, J. Sevillano, J. de Castro et al., Validation of simple indexes to assess insulin sensitivity during pregnancy in wistar and sprague-dawley rats. Am. J. Physiol. Endocrinol. Metab. 295(5), E1269–1276 (2008)CrossRefPubMed
28.
go back to reference M. Rebuffé-Scrive, R. Surwit, M. Feinglos et al., Regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus. Metabolism 42(11), 1405–1409 (1993)CrossRefPubMed M. Rebuffé-Scrive, R. Surwit, M. Feinglos et al., Regional fat distribution and metabolism in a new mouse model (C57BL/6J) of non-insulin-dependent diabetes mellitus. Metabolism 42(11), 1405–1409 (1993)CrossRefPubMed
29.
go back to reference S.Y. Park, Y.W. Kim, J.Y. Kim et al., Effect of high fat diet on insulin resistance: dietary fat versus visceral fat mass. J. Korean Med. Sci. 16(4), 386–390 (2001)CrossRefPubMedPubMedCentral S.Y. Park, Y.W. Kim, J.Y. Kim et al., Effect of high fat diet on insulin resistance: dietary fat versus visceral fat mass. J. Korean Med. Sci. 16(4), 386–390 (2001)CrossRefPubMedPubMedCentral
30.
go back to reference I. Gabriely, X.H. Ma, X.M. Yang et al., Leptin resistance during aging is independent of fat mass. Diabetes 51(4), 1016–1021 (2002)CrossRefPubMed I. Gabriely, X.H. Ma, X.M. Yang et al., Leptin resistance during aging is independent of fat mass. Diabetes 51(4), 1016–1021 (2002)CrossRefPubMed
31.
go back to reference Y. Kamari, E. Grossman, M. Oron-Herman et al., Metabolic stress with a high carbohydrate diet increases adiponectin levels. Horm. Metab. Res. 39, 384–388 (2007)CrossRefPubMed Y. Kamari, E. Grossman, M. Oron-Herman et al., Metabolic stress with a high carbohydrate diet increases adiponectin levels. Horm. Metab. Res. 39, 384–388 (2007)CrossRefPubMed
32.
go back to reference B. Yang, L. Chen, Y. Qian et al., Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats. Biochem. Biophys. Res. Commun. 341(1), 209–217 (2006)CrossRefPubMed B. Yang, L. Chen, Y. Qian et al., Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats. Biochem. Biophys. Res. Commun. 341(1), 209–217 (2006)CrossRefPubMed
33.
go back to reference G. Marek, V. Pannu, P. Shanmugham et al., Adiponectin resistance and proinflammatory changes in the visceral adipose tissue induced by fructose consumption via Ketohexokinase-dependent pathway. Diabetes 64, 508–518 (2015)CrossRefPubMed G. Marek, V. Pannu, P. Shanmugham et al., Adiponectin resistance and proinflammatory changes in the visceral adipose tissue induced by fructose consumption via Ketohexokinase-dependent pathway. Diabetes 64, 508–518 (2015)CrossRefPubMed
34.
go back to reference A. Alzamendi, D. Castrogiovanni, H.H. Ortega et al., Parametrial adipose tissue and metabolic dysfunctions induced by fructose-rich diet in normal and neonatal-androgenized adult female rats. Obesity (Silver Spring) 18(3), 441–448 (2010)CrossRef A. Alzamendi, D. Castrogiovanni, H.H. Ortega et al., Parametrial adipose tissue and metabolic dysfunctions induced by fructose-rich diet in normal and neonatal-androgenized adult female rats. Obesity (Silver Spring) 18(3), 441–448 (2010)CrossRef
35.
go back to reference K.L. Mullen, J. Pritchard, I. Ritchie et al., Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R243–R251 (2009)CrossRefPubMed K.L. Mullen, J. Pritchard, I. Ritchie et al., Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R243–R251 (2009)CrossRefPubMed
36.
go back to reference R.K. Semple, N.H. Halberg, K. Burling et al., Paradoxical elevation of high–molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 56(6), 1712–1717 (2007)CrossRefPubMedPubMedCentral R.K. Semple, N.H. Halberg, K. Burling et al., Paradoxical elevation of high–molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 56(6), 1712–1717 (2007)CrossRefPubMedPubMedCentral
37.
go back to reference H. Hirose, Y. Yamamoto, Y. Seino-Yoshihara et al., Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. J. Atheroscler. Thromb. 17(12), 1201–1211 (2010)CrossRefPubMed H. Hirose, Y. Yamamoto, Y. Seino-Yoshihara et al., Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. J. Atheroscler. Thromb. 17(12), 1201–1211 (2010)CrossRefPubMed
38.
go back to reference J.R. Kizer, A.M. Arnold, D. Benkeser et al., Total and high molecular-weight adiponectin and risk of incident diabetes in older people. Diabetes Care 35(2), 415–423 (2012)CrossRefPubMedPubMedCentral J.R. Kizer, A.M. Arnold, D. Benkeser et al., Total and high molecular-weight adiponectin and risk of incident diabetes in older people. Diabetes Care 35(2), 415–423 (2012)CrossRefPubMedPubMedCentral
39.
40.
go back to reference Y. Seino, H. Hirose, I. Saito et al., High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism 56(11), 1493–1499 (2007)CrossRefPubMed Y. Seino, H. Hirose, I. Saito et al., High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism 56(11), 1493–1499 (2007)CrossRefPubMed
Metadata
Title
Development of metabolic syndrome in high-sucrose diet fed rats is not associated with decrease in adiponectin levels
Authors
M. Aslam
S. V. Madhu
Publication date
01-10-2017
Publisher
Springer US
Published in
Endocrine / Issue 1/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1403-5

Other articles of this Issue 1/2017

Endocrine 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.